FIELD: medicine, pediatry, virology. SUBSTANCE: invention relates to preparing vaccine strain of influenza virus A/47/Johannesburg/96/7/7 (H1N1) for producing live anti-influenzal intranasal vaccine for children. Strain A/47/Johannesburg/96/7/7 (H1N1) multiplicates actively in developing chicken embryos at optimal temperature 34 C and shows temperature-sensitivity and cold adaptation. Strain is nonreactive and can be used as live anti-influenzal intranasal vaccine for administration in 3-14 old years children. EFFECT: strain indicated above, valuable anti-influenzal properties of vaccine. 1 tbl, 1 ex
Authors
Dates
2000-06-20—Published
1998-12-10—Filed